Hypnosis Antenatal Training for Childbirth (HATCh): a Randomised Controlled Trial

Antenatal hypnosis is associated with a reduced need for pharmacological interventions during childbirth. This trial seeks to determine the efficacy or otherwise of antenatal group hypnosis preparation for childbirth in late pregnancy.

Study Overview

Detailed Description

Background: Although medical interventions play an important role in preserving lives and maternal comfort they have become increasingly routine in normal childbirth. This may increase the risk of associated complications and a less satisfactory birth experience. Antenatal hypnosis is associated with a reduced need for pharmacological interventions during childbirth. This trial seeks to determine the efficacy or otherwise of antenatal group hypnosis preparation for childbirth in late pregnancy.

Methods / Design: A single centre, randomised controlled trial using a 3 arm parallel group design in the largest tertiary maternity unit in South Australia. Group 1 participants receive antenatal hypnosis training in preparation for childbirth administered by a qualified hypnotherapist with the use of an audio compact disc on hypnosis for re-enforcement; Group 2 consists of antenatal hypnosis training in preparation for childbirth using an audio compact disc on hypnosis administered by a nurse with no training in hypnotherapy; Group 3 participants continue with their usual preparation for childbirth with no additional intervention. Women > 34 < 39 weeks gestation, with a singleton, viable fetus, vertex presentation, who are not in active labour or planning a vaginal birth are eligible to participate. Allocation concealment is achieved using telephone randomisation. Participants assigned to hypnosis groups are trained as near as possible to 37 weeks gestation. Group allocations are concealed from treating obstetricians, anaesthetists, midwives and those personnel collecting and analysing data. Our sample size of 135 women / group gives the study 80% power to detect a clinically relevant fall of 20% in the number of women requiring pharmacological analgesia - the primary endpoint. We estimate that approximately 5-10% of women will deliver prior to receiving their allocated intervention. We plan to recruit 150 women / group and perform interim analyses when 150 and 300 participants have been recruited. All participants will be analysed according to the "Intention to treat" principle with comprehensive pre-planned cost- benefit and subgroup analyses.

Discussion: If effective, hypnosis would be a simple, inexpensive way to improve the childbirth experience, reduce complications associated with pharmacological interventions, yield cost savings in maternity care, and provide evidence to guide clinical practice.

Study Type

Interventional

Enrollment (Actual)

448

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • South Australia
      • Adelaide, South Australia, Australia, 5006
        • Women's and Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • women > 34 < 39 weeks gestation; singleton, viable fetus, vertex presentation, who are not in active labour (active labour is defined as cervical effacement and dilatation associated with regular uterine contractions) and who are planning a vaginal birth.

Exclusion Criteria:

  • Previous hypnosis preparation for childbirth;
  • poor understanding of English requiring translator;
  • women who are already enrolled in another pregnancy trial where analgesia requirements are an outcome measure;
  • active psychological or psychiatric problems such as: active depression requiring treatment by a psychiatrist;
  • schizophrenia;
  • prior psychosis;
  • severe intellectual disability.
  • Women with pain caused by specific pathological entities such as: congenital neuromuscular disorders; spina bifida; metastatic disease; osteoporosis; rheumatoid arthritis; fractures,are also excluded

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Usual care control
Experimental: Hypnosis + CD
Hypnosis plus audio cd on hypnosis
Active Comparator: Audio CD on Hypnosis
Audio CD on hypnosis sessions weekly on three occasions after 34 weeks gestation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The use of pharmacological analgesia during labour and childbirth will be collected from the birth register where all analgesia is documented by the attending midwife
Time Frame: Within 24 hours of the birth
Within 24 hours of the birth

Secondary Outcome Measures

Outcome Measure
Time Frame
1. Maternal rating of the overall pain experienced during labour and childbirth
Time Frame: Usually within 48 hours or before discharge from hospital
Usually within 48 hours or before discharge from hospital
2. Mode of delivery
Time Frame: Within 24 hours of the birth
Within 24 hours of the birth
3. Use of oxytocics
Time Frame: Within 24 hours of the birth
Within 24 hours of the birth
4. Postnatal depression
Time Frame: At 6 weeks and 6 months postnatal
At 6 weeks and 6 months postnatal
5. Maternal anxiety
Time Frame: At 6 weeks and 6 months postnatal
At 6 weeks and 6 months postnatal
6. Neonatal Apgar score at 5 minutes < 7
Time Frame: within 24 hours of birth
within 24 hours of birth
7. Maternal admission to the High Dependency Unit (HDU) or the Intensive Care Unit (ICU)
Time Frame: within 24 hours of birth
within 24 hours of birth
8. Maternal rating whether the birth experience was. Worse / better / same as expected
Time Frame: within 24 hours of birth
within 24 hours of birth
9. Maternal rating of control during the labour during the birth
Time Frame: within 24 hours of birth
within 24 hours of birth
10. Maternal rating whether the birth was rated positive or negative experience
Time Frame: within 24 hours of birth
within 24 hours of birth
11. Length of neonatal nursery stay
Time Frame: within 24 hours of birth
within 24 hours of birth
12. Length of maternal stay in hospital
Time Frame: within 6 months of the birth
within 6 months of the birth
13. Number of women breast feeding at discharge from hospital and at 6 weeks and 6 months
Time Frame: 6 months after birth
6 months after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marion I Andrew, FANZCA, Women's and Children's Hospital, Australia
  • Study Director: Allan M Cyna, FRCA, Women's and Children's Hospital, Australia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2005

Primary Completion (Actual)

December 1, 2010

Study Completion (Actual)

December 1, 2010

Study Registration Dates

First Submitted

January 24, 2006

First Submitted That Met QC Criteria

January 24, 2006

First Posted (Estimate)

January 25, 2006

Study Record Updates

Last Update Posted (Estimate)

June 29, 2012

Last Update Submitted That Met QC Criteria

June 28, 2012

Last Verified

December 1, 2010

More Information

Terms related to this study

Other Study ID Numbers

  • ACTRN012605000018617

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on antenatal hypnosis + audio compact disc on hypnosis

3
Subscribe